To gain insights into the mechanism by which PTPN2 regulates the proliferation and survival of KRAS-dependent tumor cells, we first checked whether PTPN2 affects the KRAS activation, using an RAS-GTP pulldown assay. The gene discussed is KRAS; the disease is neoplasm.